Overview

A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
A study to determine the safety and efficacy of albiglutide in subjects with type 2 diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Glucagon-Like Peptide 1
Insulin
Insulin Glargine
Insulin, Globin Zinc
rGLP-1 protein